12:00 AM
 | 
Oct 14, 2013
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Portola proposes follow-on

Portola Pharmaceuticals Inc. (NASDAQ:PTLA), South San Francisco, Calif.
Business: Cardiovascular, Autoimmune, Cancer
Date announced:...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >